BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10949806)

  • 21. [Antibiotic therapy in the infected diabetic foot].
    Vieru A; Mazilu G; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(4):1091-6. PubMed ID: 22276452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic foot infections. Antimicrobial therapy.
    Grayson ML
    Infect Dis Clin North Am; 1995 Mar; 9(1):143-61. PubMed ID: 7769215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparative Analysis of Antibiotic Usage in Diabetic Foot Infections Against Healing Time.
    Kruszewska K; Wesolowska-Gorniak K; Czarkowska-Paczek B
    J Foot Ankle Surg; 2021; 60(5):902-907. PubMed ID: 33820683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study.
    Hatipoglu M; Mutluoglu M; Turhan V; Uzun G; Lipsky BA; ; Sevim E; Demiraslan H; Eryilmaz E; Ozuguz C; Memis A; Ay H; Arda B; Uysal S; Motor VK; Kader C; Erturk A; Coskun O; Duygu F; Guler S; Altay FA; Ogutlu A; Bolukcu S; Yildiz S; Kandemir O; Aslaner H; Polat A; Karahocagil MK; Yasar KK; Sehmen E; Kilic S; Sunbul M; Gencer S; Bozkurt F; Yanik T; Oztoprak N; Batirel A; Sozen H; Kilic I; Celik I; Ay B; Tosun S; Kadanali A; Çomoglu S; Denk A; Hosoglu S; Aydin O; Elaldi N; Akalin S; Kandemir B; Akbulut A; Demirdal T; Balik R; Azak E; Sengoz G
    J Diabetes Complications; 2016 Jul; 30(5):910-6. PubMed ID: 26965794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial interventions for the management of diabetic foot infections.
    Senneville E
    Expert Opin Pharmacother; 2005 Feb; 6(2):263-73. PubMed ID: 15757422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients.
    Viswanathan V; Jasmine JJ; Snehalatha C; Ramachandran A
    J Assoc Physicians India; 2002 Aug; 50():1013-6. PubMed ID: 12421021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic therapy for diabetic foot infections in a tertiary care hospital in Jakarta, Indonesia.
    Radji M; Putri CS; Fauziyah S
    Diabetes Metab Syndr; 2014; 8(4):221-4. PubMed ID: 25311820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections?
    de Vries MG; Ekkelenkamp MB; Peters EJ
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):453-6. PubMed ID: 24220766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients].
    Ding Q; Li DQ; Wang PH; Chu YJ; Meng SY; Sun Q
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):228-31. PubMed ID: 22490791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?
    Lipsky BA
    Clin Microbiol Infect; 2007 Apr; 13(4):351-3. PubMed ID: 17359317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory markers as risk factors for infection with multidrug-resistant microbes in diabetic foot subjects.
    Noor S; Borse AG; Ozair M; Raghav A; Parwez I; Ahmad J
    Foot (Edinb); 2017 Aug; 32():44-48. PubMed ID: 28802182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection?
    Lebowitz D; Gariani K; Kressmann B; Dach EV; Huttner B; Bartolone P; Lê N; Mohamad M; Lipsky BA; Uçkay I
    Int J Infect Dis; 2017 Jun; 59():61-64. PubMed ID: 28450198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic foot.
    Ambrosch A; Halevy D; Fwity B; Brin T; Lobmann R
    Int J Low Extrem Wounds; 2013 Jun; 12(2):100-5. PubMed ID: 23771610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical challenges and unmet needs in the management of complicated skin and skin structure, and soft tissue infections.
    Turina M; Cheadle WG
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-23-36. PubMed ID: 23577495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetanus complicating a polymicrobial diabetic foot infection: case presentation and review of current treatment.
    Thordarson DB; Perry JR; Patzakis MJ
    Foot Ankle Int; 1995 Feb; 16(2):97-9. PubMed ID: 7767456
    [No Abstract]   [Full Text] [Related]  

  • 37. Surgical site and vascular infections: treatment and prophylaxis.
    Homer-Vanniasinkam S
    Int J Infect Dis; 2007 May; 11 Suppl 1():S17-22. PubMed ID: 17603949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Infection and diabetic foot].
    Senneville E
    Rev Med Interne; 2008 Sep; 29 Suppl 2():S243-8. PubMed ID: 18822250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic.
    Tentolouris N; Jude EB; Smirnof I; Knowles EA; Boulton AJ
    Diabet Med; 1999 Sep; 16(9):767-71. PubMed ID: 10510954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.
    Lipsky BA; Berendt AR; Cornia PB; Pile JC; Peters EJ; Armstrong DG; Deery HG; Embil JM; Joseph WS; Karchmer AW; Pinzur MS; Senneville E;
    Clin Infect Dis; 2012 Jun; 54(12):e132-73. PubMed ID: 22619242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.